News Update Clinical Study in the Journa

News Update Clinical Study in the Journal of Clinical Oncology Reports Patients With Diffuse Large B-Cell Lymphoma Receiving Oral REVLIMID With Standard R-CHOP Achieved 98% Overall Response Rate and 80% Complete Response Rate http://ow.ly/2M3Hac

Advertisements